{"id":2523,"date":"2016-06-01T23:16:00","date_gmt":"2016-06-01T23:16:00","guid":{"rendered":"https:\/\/cdafound.org\/?p=2523"},"modified":"2025-01-15T20:28:13","modified_gmt":"2025-01-15T20:28:13","slug":"mitigating-the-burden-of-hepatitis-c-virus-among-people-who-inject-drugs-in-belgium","status":"publish","type":"post","link":"https:\/\/cdafound.org\/fr\/mitigating-the-burden-of-hepatitis-c-virus-among-people-who-inject-drugs-in-belgium\/","title":{"rendered":"Att\u00e9nuer le fardeau du virus de l&#039;h\u00e9patite C chez les consommateurs de drogues injectables en Belgique"},"content":{"rendered":"<h2 class=\"wp-block-heading\">R\u00e9sum\u00e9<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">Contexte et objectifs<\/h3>\n\n\n\n<p>En 2010, il y avait environ 10 100 PID en Belgique et 43% (34%-57%) \u00e9taient infect\u00e9s par le VHC. La compr\u00e9hension de la dynamique de transmission du VHC dans les populations \u00e0 haut risque et l&#039;\u00e9valuation de l&#039;impact potentiel de strat\u00e9gies de traitement am\u00e9lior\u00e9es contre le VHC n\u00e9cessitent des donn\u00e9es \u00e9pid\u00e9miologiques solides et une mod\u00e9lisation math\u00e9matique.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><br>M\u00e9thodes<\/h3>\n\n\n\n<p>La transmission du VHC a \u00e9t\u00e9 mod\u00e9lis\u00e9e \u00e0 l&#039;aide de cohortes pour suivre l&#039;incidence et la pr\u00e9valence du VHC parmi les UDI actifs dans la population g\u00e9n\u00e9rale des UDI, l&#039;OST et le NSP. Les hypoth\u00e8ses du mod\u00e8le ont \u00e9t\u00e9 d\u00e9riv\u00e9es de la litt\u00e9rature publi\u00e9e et du consensus des experts. L&#039;impact relatif de l&#039;augmentation du nombre d&#039;UDI trait\u00e9s avec de nouveaux AAD oraux a \u00e9t\u00e9 pris en compte.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><br>R\u00e9sultats<\/h3>\n\n\n\n<p>Si le paradigme de transmission actuel se poursuit, il y aura 2645 PID infect\u00e9s par le VHC en 2030. Le traitement annuel de 30 (1% de la population de 2015) ou 120 (4% de la population de 2015) PID infect\u00e9s par le VHC avec des AAD oraux entra\u00eenera des r\u00e9ductions de 5% et 25%, respectivement, chez les PDI infect\u00e9s par le VHC d&#039;ici 2030. Le traitement de 370 PID par an (12,51 TTP1T de la population de 2015) entra\u00eenera une r\u00e9duction&gt; 901 TTP1T d&#039;ici 2030.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><br>Conclusion<\/h3>\n\n\n\n<p>Le traitement d\u2019un petit nombre de consommateurs de drogues injectables peut entra\u00eener une r\u00e9duction substantielle de la pr\u00e9valence du VHC dans cette population. Cependant, des niveaux \u00e9lev\u00e9s de traitement sont n\u00e9cessaires pour r\u00e9duire le pool viral et donc le risque d\u2019infections secondaires. Cette analyse soutient la mise en \u0153uvre d\u2019une strat\u00e9gie de d\u00e9pistage et de traitement chez les consommateurs de drogues injectables lorsqu\u2019elle est combin\u00e9e \u00e0 une expansion des programmes de r\u00e9duction des risques.<\/p>\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-outline is-style-outline--1\"><a class=\"wp-block-button__link has-text-color wp-element-button\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27382943\/\" target=\"_blank\" rel=\"noreferrer noopener\">Lire le rapport complet<\/a><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Summary Background and Aims In 2010, there were an estimated 10 100 PWID in Belgium and 43% (34%-57%) were HCV infected. Understanding HCV transmission dynamics in high-risk populations and assessing the potential impact of improved HCV treatment strategies requires robust epidemiological data and mathematical modeling. Methods HCV transmission was modeled using cohorts to track HCV [&hellip;]<\/p>\n","protected":false},"author":24,"featured_media":3245,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[10,16],"publication-author":[488,1124,1125,1122,1123,494,1099],"class_list":["post-2523","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","tag-hcv","tag-pwid","publication-author-blach-s","publication-author-bourgeois-s","publication-author-brixko-c","publication-author-mathei-c","publication-author-mulkay-jp","publication-author-razavi-h","publication-author-robaeys-g"],"acf":[],"_links":{"self":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/2523","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/comments?post=2523"}],"version-history":[{"count":6,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/2523\/revisions"}],"predecessor-version":[{"id":7579,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/2523\/revisions\/7579"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/media\/3245"}],"wp:attachment":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/media?parent=2523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/categories?post=2523"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/tags?post=2523"},{"taxonomy":"publication-author","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/publication-author?post=2523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}